Doctors and drug costs
Executive Summary
Physicians infrequently communicate with patients about the cost of new medication prescriptions, according to a study in the November issue of the American Journal of Managed Care. Researchers from the University of California assessed patient and physician surveys and transcriptions of 185 office visits from 1999. "For one third of newly prescribed medications, physicians discussed an aspect of acquisition, including cost and insurance coverage for 12%, logistics of obtaining medications for 18%, and medication supply for 9%," Derjung Tarn et al. state. "Interventions should target improving physician knowledge about helping patients achieve affordable medication regimens, as well as stressing the importance of recognizing and addressing cost and acquisition issues with patients," the authors conclude...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.